Literature DB >> 31399515

Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway.

Manabu Hayashi1,2, Takeshi Machida3, Yumi Ishida1, Yusuke Ogata1, Tomoko Omori1, Mika Takasumi1,2, Yuichi Endo1, Toshiyuki Suzuki4, Masayuki Sekimata4, Yoshimi Homma5, Masahito Ikawa6, Hiromasa Ohira2, Teizo Fujita7, Hideharu Sekine1.   

Abstract

The complement system, a part of the innate immune system, can be activated via three different pathways. In the alternative pathway, a factor D (FD) plays essential roles in both the initiation and the amplification loop and circulates as an active form. Mannose-binding lectin-associated serine proteases (MASPs) are key enzymes of the lectin pathway, and MASP-1 and/or MASP-3 are reported to be involved in the activation of FD. In the current study, we generated mice monospecifically deficient for MASP-1 or MASP-3 and found that the sera of the MASP-1-deficient mice lacked lectin pathway activity, but those of the MASP-3-deficient mice lacked alternative pathway activity with a zymogen FD. Furthermore, the results indicate that MASP-3 but not MASP-1 activates the zymogen FD under physiological conditions and MASP-3 circulates predominantly as an active form. Therefore, our study illustrates that, in mice, MASP-3 orchestrates the overall complement reaction through the activation of FD.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31399515     DOI: 10.4049/jimmunol.1900605

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis.

Authors:  Manabu Hayashi; Kazumichi Abe; Masashi Fujita; Atsushi Takahashi; Hideharu Sekine; Hiromasa Ohira
Journal:  JHEP Rep       Date:  2022-04-29

2.  An Emotional Molecular Pathway in Pulmonary Hypertension-Alternative Complement System.

Authors:  Gabriele Grunig; Nedim Durmus
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

Review 3.  Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration.

Authors:  Emilie Grarup Jensen; Thomas Stax Jakobsen; Steffen Thiel; Anne Louise Askou; Thomas J Corydon
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

Review 4.  Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy.

Authors:  Eleni Gavriilaki; Vincent T Ho; Wilhelm Schwaeble; Thomas Dudler; Mohamed Daha; Teizo Fujita; Sonata Jodele
Journal:  Exp Hematol Oncol       Date:  2021-12-19

Review 5.  Proprotein Convertases and the Complement System.

Authors:  József Dobó; Andrea Kocsis; Ráhel Dani; Péter Gál
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

6.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 7.  Tackling COVID-19 infection through complement-targeted immunotherapy.

Authors:  Sonata Jodele; Jörg Köhl
Journal:  Br J Pharmacol       Date:  2020-07-27       Impact factor: 9.473

Review 8.  The Influence of the Lectin Pathway of Complement Activation on Infections of the Respiratory System.

Authors:  Anna S Świerzko; Maciej Cedzyński
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561

Review 9.  Tipping the balance: intricate roles of the complement system in disease and therapy.

Authors:  Richard B Pouw; Daniel Ricklin
Journal:  Semin Immunopathol       Date:  2021-10-26       Impact factor: 9.623

Review 10.  Components of the Lectin Pathway of Complement in Solid Tumour Cancers.

Authors:  Maciej Cedzyński; Anna S Świerzko
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.